Delivery Order SPE2DB22D9207-SPE2DB24FH4YA
Award Date 3/4/24
Potential Completion Date 3/25/24
Potential Value $9.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of EXPAREL 133 MG/10 ML VIAL 10ML. The contract has a ceiling value of $4,521.66 and an ultimate completion date of April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The fixed-price contract has a ceiling value of $7,461.66 and a completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (SPE2DB) that DMS Pharmaceutical Group holds with the DLA, valued at up to $4,999,999 through the end of 2025, for the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide EXPAREL 266 MG/20 ML VIAL 20ML. This $49,744.40 delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group to fulfill recurring pharmaceutical supply needs for military health facilities worldwide. The IDC, which runs through December 31, 2025, allows the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of EXPAREL 1.3% 20ML 10S. The contract, valued at $14,923.32, has a completion date of May 16, 2024 and is not set aside. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of EXPAREL 133 MG/10 ML VIAL 10ML. This $1,427.82 contract award is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program, which enables the agency to fulfill recurring pharmaceutical supply needs of military health facilities worldwide. DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $9,948.88 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product, with a period of performance through December 2, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $5,711.28, has a completion date of May 30, 2024 and was awarded on May 8, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to deliver EXPAREL 266 MG/20 ML VIAL 20ML. The firm fixed-price contract has a potential value of $29,846.64 and a completion date of March 7, 2024. This delivery order is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, which enables DLA to issue orders for a wide range...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 266 mg/20 ml vials of the pharmaceutical product EXPAREL. The contract has a potential value of $8,889.48 and a completion date of February 22, 2024. This Delivery Order contract is issued under DMS Pharmaceutical Group's larger Indefinite Delivery contract 4600082013 with DLA, valued up to $4,999,999, which enables the...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 266 mg/20 mL vials of EXPAREL, a non-opioid pain medication. The potential value of the contract is $4,974.44, with a completion date of February 27, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract 4600082013 with the Defense...